Quan Capital

Portfolio Co Investors 2026 for Quan Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Quan Capital accounts for 11 tracked companies with verified cap-table data, 11 of which disclose round sizes totalling $1B. The median disclosed raise is $76M, and the largest is Windward Bio at $200M, ahead of Design Therapeutics ($170M) and Pinnacles Medical ($134M).

The names that recur most often on these co-invested cap tables are Quan Capital (11 companies), RA Capital Management (4 companies), Logos Capital (3 companies), OrbiMed (2 companies), SR One (2 companies), Qiming Venture Partners (2 companies). By latest disclosed round, the market skews Series B (6), Series A (5).

Best funded Quan Capital companies

  1. Windward Bio — $200M (latest: Series A)
  2. Design Therapeutics — $170M (latest: Series B)
  3. Pinnacles Medical — $134M (latest: Series B)
  4. Eluminex Biosciences — $100M (latest: Series B)
  5. Citrine Medicine — $80M (latest: Series A)
  6. Interius BioTherapeutics — $76M (latest: Series A)
  7. Crescendo Biologics — $70M (latest: Series B)
  8. Alebund Pharmaceuticals — $60M (latest: Series B)
  9. Yuanyin Bio — $56M (latest: Series A)
  10. Kira Pharmaceuticals — $46M (latest: Series B)
  11. Walking Fish Therapeutics — $23M (latest: Series A)

Quan Capital — related firms and companies (54)

Quan Capital alternatives · All research reports